期刊文献+

miR-106b对人肝癌细胞HepG2细胞迁移和侵袭能力的影响 被引量:2

Effects of miR-106b on migration and invasion of HepG2 cell
下载PDF
导出
摘要 目的探讨miR-106b对人肝癌细胞HepG2迁移和侵袭能力的影响。方法分别用阴性对照(NC组)、miR-106b模拟物(miR-106b组)和miR-106b抑制物(miR-106b-in组)转染HepG2细胞,实时PCR检测三组HepG2细胞miR-106b的表达,划痕实验、Transwell实验、3D培养实验检测三组HepG2细胞的迁移及侵袭能力的差异。结果实时PCR显示miR-106b组细胞miR-106b相对表达量为(17.83±1.66),miR-106b-in组为(0.32±0.07),差异有统计学意义(P<0.05);NC组细胞24 h及48 h划痕修复率分别为(47±3)%、(71±6)%,miR-106b组分别为(65±5)%、(99±1)%,miR-106b-in组分别为(38±3)%、(56±4)%,组间两两比较差异均有统计学意义(P<0.05);Transwell侵袭实验显示,NC组的穿室细胞数为(58±10)个,miR-106b组为(116±19)个,miR-106b-in组为(38±6)个,组间两两比较差异均有统计学意义(P<0.05);3D培养实验显示,20个200倍视野下,miR-106b组无伪足的球形细胞数为(3±1)个,明显少于NC组的(7±2)个及miR-106b-in组的(11±2)个,差异均有统计学意义(P<0.05)。结论 miR-106b能明显增强HepG2细胞的迁移和侵袭能力。 Objective To investigate the influence of miR-106b on HepG2 cell's migration and invasion.Methods HepG2 cells were respectively transfected with negative control (NC group), miR-106b analogue (miR-106bgroup) and miR-106b inhibitor (miR-106b-in group). Real-time PCR was used to detect the expression of miR-106b inHepG2 cells. The differences of HepG2 cells' migration and invasion in the three groups were detected and compared byWound Healing assay, Transwell assay and 3D spheroid invasion assay. Results Real-time PCR showed that the cells'miR-106b relative expression of the miR-106b group was (17.83 ± 1.66), which was significantly higher than (0.32 ±0.07) of the miR-106b-in group (P〈0.05). The cells' 24 h and 48 h scratch repair rates of the NC group were (47±3)%and (71±6)% respectively, which were significantly lower than corresponding (65±5)% and (99±1)% of the miR-106bgroup (P〈0.05). The Transwell experiment indicated that the migrated cells count in the NC group, the miR-106b groupand the miR-106b-in group were respectively (58±10), (116±19) and (38±6), and the differences among the three groupswere statistically significant (P〈0.05) as well. Under 200 magnified visual field, 3D culture experiment expressed that thenumbers of globular cells without pseudopodia in the miR-106b group, miR-106b-in group, NC group were (3±1), (11±2),and (7±2), respectively, and the differences were statistically significant (P〈0.05). Conclusion MiR-106b can signifi-cantly enhance HepG2 cell's migration and invasion.
出处 《海南医学》 CAS 2018年第5期593-595,共3页 Hainan Medical Journal
基金 广东省广州市科技和信息化局项目(编号:2014J4100063)
关键词 HEPG2细胞 miR-106b 迁移 侵袭 HepG2 cell miR-106b Migration Invasion
  • 相关文献

参考文献3

二级参考文献23

  • 1He W, He S, Wang Z, et al. Astrocyte elevated gene-1 (AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/13-catenin signaling [J]. BMC Cancer, 2015,15(3) : 107-114.
  • 2Tian W, Han X, Yan M, et al. Structure-based discovery of a novel inhibitor targeting the 13-catenin/Tcf4 interaction [J]. Biochemistry, 2012,51 (2) : 724-731.
  • 3Blais A, van Oevelen C J, Margueron R, et al. Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit [J]. J Cell Biol,2007, 179(7) : 1399-1412.
  • 4Yamashita T, Ji J, Budhu A. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitorcell features [J]. Gastroenterology,2009,136 (3) : 1012-1024.
  • 5Liu J, Ding X, Tang J, et al. Enhancement of canonical Wnt/β-Catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells [J]. PLos one, 2011,6( 11 ) : e27496.
  • 6Moon RT, Kohn AD, De Ferrari GV, et al. WNT and beta- catenin signalling: diseases and therapies [J]. Nat Rev Genet, 2004,5 ( 9 ) : 691-701.
  • 7胡明星,李杰,秦涛,张莉.96例肝细胞肝癌术后复发危险因素分析[J].中国当代医药,2011,18(7):5-6. 被引量:11
  • 8邓碧兰,庄燕玲.肝病患者出凝血四项和D-D的检测分析[J].海南医学,2011,22(8):117-119. 被引量:17
  • 9林东昕.肿瘤的遗传易感因素[J].海南医学,1999,10(6):83-85. 被引量:1
  • 10苗艳艳,孔心涓,田字彬.原发性肝癌危险因素及其致癌机制的研究进展[J].青岛大学医学院学报,2012,48(1):91-92. 被引量:18

共引文献23

同被引文献8

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部